他拉唑帕利(BMN-673)是是一種高效的口服的多核苷酸ADP-核糖聚合酶(PARP1/2)抑制劑,Ki 值分別為 1.2 nM 和 0.87 nM,用于治療乳腺癌BRCA突變的晚期乳腺癌患者。
-
默認(rèn)
常備現(xiàn)貨
-
純度
- 請(qǐng)選擇
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
規(guī)格
- 請(qǐng)選擇
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空選項(xiàng)
-
6-Fluoro-4-nitroisobenzofuran-1(3H)-one
-
BD2379141207453-90-495%
-
¥336.005g常備現(xiàn)貨
-
4-Fluorobenzaldehyde
-
BD33707459-57-495%
-
¥299.001kg常備現(xiàn)貨
-
4-Amino-6-fluoroisobenzofuran-1(3H)-one
-
BD2625431207453-91-595%
-
¥1695.001g常備現(xiàn)貨
-
1-Methyl-1,2,4-triazole
-
BD593016086-21-198%
-
¥568.00100g常備現(xiàn)貨
-
1-Methyl-1H-1,2,4-triazole-5-carbaldehyde
-
BD24630399651-37-398%
-
¥8980.005g常備現(xiàn)貨
-
Methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate
-
BD5566611322616-36-395%
-
¥18275.001g
-
5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one
-
BD5566621207454-56-597%
-
¥4999.0025mg
-
(Z)-6-Fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one
-
BD008080721322616-34-198%
-
¥24122.001g
-
Methyl (2S,3S)-7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate
-
BD008453261373329-52-297%
-
¥7760.00250mg
-
(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one 4-methylbenzenesulfonate
-
BD011169851373431-65-298%
-
¥7384.00100mg